Screen Reader Mode Icon Check SCREEN READER MODE to make this survey compatible with screen readers. Content Question Title * 1. Please enter your name (this is required according to the Medicinal Products Act). OK Question Title * 2. Any mistakes you noticed (e.g. incorrect or misleading information, spelling) OK Question Title * 3. Any content you missed OK Question Title * 4. Most frequently read / most important content Eligibility Leukapheresis and Bridging Lymphodepletion, CAR T-cell Transfusion and Monitoring Toxicity Follow up Calculator Literature OK Question Title * 5. Most frequently used (instant button) Favorites Calculator Literature Contact OK Question Title * 6. Specific content is easy to find. Strongly agree Agree Neither agree nor disagree Disagree Strongly disagree OK Question Title * 7. The content is clearly structured. Strongly agree Agree Neither agree nor disagree Disagree Strongly disagree OK Question Title * 8. The content is uptodate. Strongly agree Agree Neither agree nor disagree Disagree Strongly disagree OK Question Title * 9. The content is correct. Strongly agree Agree Neither agree nor disagree Disagree Strongly disagree OK Question Title * 10. The content is complete. Strongly agree Agree Neither agree nor disagree Disagree Strongly disagree OK Question Title * 11. The content improves the daily clinical practice. Strongly agree Agree Neither agree nor disagree Disagree Strongly disagree OK Question Title * 12. The chapters Eligibility, Leukapheresis, Bridging and CAR T cell transfusion... Strongly agree Agree Neither agree or disagree Disagree Strongly disagree ... are comprehensively presented. ... are comprehensively presented. Strongly agree ... are comprehensively presented. Agree ... are comprehensively presented. Neither agree or disagree ... are comprehensively presented. Disagree ... are comprehensively presented. Strongly disagree ... include new information I did not know about of so far. ... include new information I did not know about of so far. Strongly agree ... include new information I did not know about of so far. Agree ... include new information I did not know about of so far. Neither agree or disagree ... include new information I did not know about of so far. Disagree ... include new information I did not know about of so far. Strongly disagree ... facilitate the steps prior to the application of CARs and BiTEs. ... facilitate the steps prior to the application of CARs and BiTEs. Strongly agree ... facilitate the steps prior to the application of CARs and BiTEs. Agree ... facilitate the steps prior to the application of CARs and BiTEs. Neither agree or disagree ... facilitate the steps prior to the application of CARs and BiTEs. Disagree ... facilitate the steps prior to the application of CARs and BiTEs. Strongly disagree OK Question Title * 13. The toxicity chapter ... Strongly agree Agree Neither agree or disagree Disagree Strongly disagree ... is comprehensively presented. ... is comprehensively presented. Strongly agree ... is comprehensively presented. Agree ... is comprehensively presented. Neither agree or disagree ... is comprehensively presented. Disagree ... is comprehensively presented. Strongly disagree ... includes new information I did not know about of so far. ... includes new information I did not know about of so far. Strongly agree ... includes new information I did not know about of so far. Agree ... includes new information I did not know about of so far. Neither agree or disagree ... includes new information I did not know about of so far. Disagree ... includes new information I did not know about of so far. Strongly disagree ... facilitates the toxicity management of CARs and BiTEs. ... facilitates the toxicity management of CARs and BiTEs. Strongly agree ... facilitates the toxicity management of CARs and BiTEs. Agree ... facilitates the toxicity management of CARs and BiTEs. Neither agree or disagree ... facilitates the toxicity management of CARs and BiTEs. Disagree ... facilitates the toxicity management of CARs and BiTEs. Strongly disagree OK NEXT